Luthra Suvitesh, Masraf Hannah, Sef Davorin, Thirukumaran David, Miskolczi Szabolcs, Velissaris Theodore
Department of Cardiac Surgery, Wessex Cardiothoracic Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
Cardiovasc Diagn Ther. 2025 Aug 30;15(4):770-780. doi: 10.21037/cdt-2025-113. Epub 2025 Aug 26.
There is a lack of evidence on association between gender specific differences in obesity and cardiovascular risk after isolated surgical aortic valve replacement (AVR) and its impact on outcomes and long-term survival. The aim of this study was to assess the impact of obesity on perioperative outcomes and long-term survival after isolated AVR.
In this retrospective, single-centre study, we included all patients who underwent isolated AVR between April 2000 and December 2019 from the cardiac surgery database of the Southampton General Hospital (Patient Administration System, e-CAMIS, Yeadon, Leeds, UK). Patients with infective endocarditis, re-sternotomy, other concomitant cardiac procedures, homografts, autografts and emergency operations were excluded. Univariable regression analysis was performed to identify predictors of in-hospital mortality. Hazard ratios were calculated using a Cox proportional hazards model.
Total of 2,398 patients were included in the study and two groups of patients were compared: body mass index (BMI) 25-34.9 kg/m (n=2,000) and BMI ≥35 kg/m (n=398) based on sensitivity modelling. Actuarial survival was comparable across BMI groups at 12.5and 12.7 years for BMI 25-34.9 kg/m and BMI ≥35 kg/m, respectively (P=0.75 log-rank). Long-term survival was specifically worse for patients with high BMI and composite cardiovascular risk of hypertension, diabetes mellitus, and current smoking [hazard ratio (HR) 1.93, 95% confidence interval (CI): 1.45-2.58, P<0.001] and patients with moderate-to-severe patient prosthesis mismatch (PPM) (effective orifice areas index ≤0.85 cm/m) (HR 1.17 95% CI: 0.98-1.39, P=0.08). Median survival time for females was 11.5 years [interquartile range (IQR): 10.3-12.3 years] versus 14.2 years (IQR: 12.7-15.7 years) for males (log-rank P=0.006), although gender was not a significant predictor of long-term survival after adjusting for covariates. Moderate-severe PPM was associated with significantly worse survival in females (log-rank P<0.01), compared to males for whom this difference was not significant (log-rank P=0.21).
Obesity with composite risk factors (hypertension, diabetes mellitus and active smoking) is associated with adverse survival. We did not observe gender-specific differences in long-term survival among specific BMI groups of patients.
关于单纯外科主动脉瓣置换术(AVR)后肥胖的性别特异性差异与心血管风险之间的关联及其对预后和长期生存的影响,目前缺乏证据。本研究的目的是评估肥胖对单纯AVR术后围手术期预后和长期生存的影响。
在这项回顾性单中心研究中,我们纳入了2000年4月至2019年12月间在南安普敦总医院心脏外科数据库(患者管理系统,e-CAMIS,英国利兹耶登)接受单纯AVR手术的所有患者。排除感染性心内膜炎、再次开胸手术、其他同期心脏手术、同种异体移植物、自体移植物和急诊手术患者。进行单变量回归分析以确定院内死亡的预测因素。使用Cox比例风险模型计算风险比。
本研究共纳入2398例患者,基于敏感性建模将患者分为两组进行比较:体重指数(BMI)25 - 34.9 kg/m²(n = 2000)和BMI≥35 kg/m²(n = 398)。BMI为25 - 34.9 kg/m²和BMI≥35 kg/m²的患者在12.5年和12.7年时的精算生存率相当(P = 0.75,对数秩检验)。BMI高且合并高血压、糖尿病和当前吸烟等复合心血管风险的患者长期生存情况特别差[风险比(HR)1.93,95%置信区间(CI):1.45 - 2.58,P < 0.001],以及中度至重度人工瓣膜 - 患者不匹配(PPM)(有效瓣口面积指数≤0.85 cm²/m²)的患者(HR 1.17,95% CI:0.98 - 1.39,P = 0.08)。女性的中位生存时间为11.5年[四分位间距(IQR):10.3 - 12.3年],而男性为14.2年(IQR:12.7 - 15.7年)(对数秩检验P = 0.006),尽管在调整协变量后性别并非长期生存的显著预测因素。与男性相比,中度至重度PPM与女性生存率显著降低相关(对数秩检验P < 0.01),而男性的这种差异不显著(对数秩检验P = 0.21)。
伴有复合风险因素(高血压、糖尿病和当前吸烟)的肥胖与不良生存相关。我们未观察到特定BMI组患者在长期生存方面存在性别特异性差异。